Trinity Innovation Fund logo

Trinity Innovation Fund

Asia, Beijing, China, Beijing

Description

Trinity Innovation Fund is a fund management company that mainly focuses its investments on pharmaceutical innovation projects.

Investor Profile

Trinity Innovation Fund has backed more than 4 startups, with 2 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series C, Seed rounds (top funding stages).
  • Majority of deals are located in United States, China.
  • Strong thematic focus on Biotechnology, Biopharma, Pharmaceutical.

Stage Focus

  • Series A (50%)
  • Series C (25%)
  • Seed (25%)

Country Focus

  • United States (50%)
  • China (50%)

Industry Focus

  • Biotechnology
  • Biopharma
  • Pharmaceutical
  • Neuroscience
  • Health Care
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Trinity Innovation Fund frequently co-invest with?

A
North America, Massachusetts, United States, Waltham
Co-Investments: 1
Johnson & Johnson Innovation – JJDC
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
LIGHTHOUSE
Asia, Beijing, China, Beijing
Co-Investments: 1
KTB Network
Asia, Kyonggi-do, South Korea, Seongnam
Co-Investments: 1
F-Prime Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Delta Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Partners Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Quan Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Eight Roads Ventures
Europe, England, United Kingdom, London
Co-Investments: 1
CDIB Capital
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1

What are some of recent deals done by Trinity Innovation Fund?

Bivision

Shanghai, Shanghai, China

Bivision is a biomedical enterprise focusing on the research and development of targeted radiopharmaceuticals (TRT).

BiopharmaBiotechnologyHealth Diagnostics
Series AJan 17, 2025
Amount Raised: $13,515,358
Rigerna

Fengtai, Beijing, China

Rigerna develops unique small nucleic acid medicines and innovative nucleic acid therapies for nonliver tissues.

BiopharmaHealth CarePharmaceutical
SeedOct 21, 2024
Amount Raised: $14,046,917
Adcentrx Therapeutics

San Diego, California, United States

Adcentrx is a biotechnology company focused on therapeutic development for cancer and other life-threatening diseases

BiotechnologyPharmaceutical
Series AApr 24, 2023
Amount Raised: $51,000,000
XWPharma

Redwood City, California, United States

XWPharma is a neuroscience biotech company that is researching new medicines for sleep, neuropsychiatric, and other neglected CNS illnesses.

BiopharmaBiotechnologyNeuroscience
Series CSep 17, 2020
Amount Raised: $40,000,000

Find More Investors Like Trinity Innovation Fund

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Trinity Innovation Fund | Pipeseed